NCT03547479

Brief Summary

This project proposes to develop and pilot a novel smart phone-based intervention to improve tuberculosis (TB) treatment adherence in Cambodia, which integrates video-enabled Directly Observed Treatment (vDOT) with an automated rewards system that transfers mobile money and eventual phone ownership to compliant patients. The results will be of immediate relevance to Cambodia's National TB Control Program (which is partnering with us), the major implementing field partner Operation ASHA (a leading TB-focused nonprofit organization), as well as other TB control programs seeking new alternatives to improving adherence, especially where traditional DOT may be infeasible or costly, and outside the area of TB where adherence to treatment is critical, such as HIV, and will provide key insights into mobile health (mHealth) programs in a setting relevant to other developing countries. The project will involve building new capacity in Cambodia for behavioral research, mHealth,and communications through hands-on training for study staff in-country, and through general training sessions for internal and external stakeholders.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2019

Shorter than P25 for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 22, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 6, 2018

Completed
11 months until next milestone

Study Start

First participant enrolled

May 1, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

April 5, 2024

Status Verified

April 1, 2024

Enrollment Period

7 months

First QC Date

May 22, 2018

Last Update Submit

April 3, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Feasibility: % patients correctly using the system

    % patients correctly using the system without phone theft, breakages or discrepancies in incentive distribution

    6 months

Secondary Outcomes (4)

  • Missed treatment

    6 months

  • Compliance

    6 months

  • Treatment default

    6 months

  • Cure

    5 and 8 months

Study Arms (3)

Control

NO INTERVENTION

Participants receive current standard of care (DOTS)

VDOT only

EXPERIMENTAL

Participants receive daily DOTS treatment with video-enabled mobile monitoring, but also maintain regular supervisory checks

Behavioral: VDOT

VDOT + mobile money incentives

EXPERIMENTAL

Participants receive daily DOTS treatment with video-enabled mobile monitoring supplemented with mobile money incentives, but also maintain regular supervisory checks

Behavioral: VDOT + mobile money

Interventions

VDOTBEHAVIORAL

In VDOT, reminder notifications are sent x minutes prior to the scheduled pill time, and continue every y minutes until the user sends a video of themselves taking their pill via the app. Instructions will be provided in Khmer. The web system has an administrator component whereby a healthcare provider can log in via the Internet to monitor and validate all the videos received that day, and reasons for non-submission.

VDOT only

The VDOT intervention above will be paired with financial incentives in the form of mobile payments in one of the experimental arms.

VDOT + mobile money incentives

Eligibility Criteria

Age21 Years+
Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 21 years or more;
  • Diagnosis of TB at healthcare facility (Clinical symptoms consistent with pulmonary TB and sputum test positive);
  • Willing to comply with the study procedures;
  • Resident at a fixed address within feasible travelling distance to the site and likely to remain resident there for the foreseeable future;
  • Willing to have directly observed therapy;
  • Willing and able to provide written informed consent in English/Khmer.

You may not qualify if:

  • Extra-pulmonary TB or suspected rifampicin resistance;
  • Underlying serious chronic diseases (such as liver or kidney disease, active malignancy, poorly-controlled diabetes);
  • History of myocardial infarction, congestive cardiac failure, cardiac arrhythmias or family history of Long QT Syndrome;
  • Current alcohol or drug abuse;
  • Pregnancy;
  • Inability to take oral medication or known allergy to one or more of the study drugs.
  • Any other significant condition that would, in the opinion of the investigator, compromise the patient's safety or outcome in the trial or lead to poor compliance with study visits and protocol requirements;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Tuberculosis, Pulmonary

Condition Hierarchy (Ancestors)

TuberculosisMycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsRespiratory Tract InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Joanne Yoong

    University of Southern California

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: The study design consists of (a) 4 qualitative focus groups (b) a pretest of 10 patient (c) a pilot randomised study of 60 patients and (d) interviews of stakeholders including healthcare professionals and policymakers
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Compliance Manager

Study Record Dates

First Submitted

May 22, 2018

First Posted

June 6, 2018

Study Start

May 1, 2019

Primary Completion

December 1, 2019

Study Completion

December 1, 2019

Last Updated

April 5, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share